Goodwill and Intangible Assets, net (Tables)

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Indefinite-Lived Intangible Assets

The following table presents both definite and indefinite lived intangible assets as of September 30, 2022, comprised primarily of acquired product rights related to the EPI Health Acquisition:

	Initial Carrying Value		Accumulated Amortization		Net Book Value		Remaining Useful Life (Years)
Rhofade	$	15,500	$	575	$	14,925	14.5
Wynzora	2,000		74		1,926		14.5
Minolira	8,500		315		8,185		14.5
Cloderm	1,000		37		963		14.5
Sitavig	2,000		111		1,889		9.5
Website domain	75		—		75		—
Total intangible assets	$	29,075	$	1,112	$	27,963

Schedule of Finite-Lived Intangible Assets

The following table presents both definite and indefinite lived intangible assets as of September 30, 2022, comprised primarily of acquired product rights related to the EPI Health Acquisition:

	Initial Carrying Value		Accumulated Amortization		Net Book Value		Remaining Useful Life (Years)
Rhofade	$	15,500	$	575	$	14,925	14.5
Wynzora	2,000		74		1,926		14.5
Minolira	8,500		315		8,185		14.5
Cloderm	1,000		37		963		14.5
Sitavig	2,000		111		1,889		9.5
Website domain	75		—		75		—
Total intangible assets	$	29,075	$	1,112	$	27,963

Schedule of Annual Amortization Expense

The following table represents annual amortization of definite lived intangible assets for the next five fiscal years, and thereafter:

2022	$	505
2023	2,000
2024	2,005
2025	2,000
2026	2,000
Thereafter	19,378
Total amortization	$	27,888